You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

MODAFINIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Modafinil

A generic version of MODAFINIL was approved as modafinil by ORBION PHARMS on September 26th, 2012.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MODAFINIL?
  • What are the global sales for MODAFINIL?
  • What is Average Wholesale Price for MODAFINIL?
Drug patent expirations by year for MODAFINIL
Drug Prices for MODAFINIL

See drug prices for MODAFINIL

Drug Sales Revenue Trends for MODAFINIL

See drug sales revenues for MODAFINIL

Recent Clinical Trials for MODAFINIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kuwait UniversityEarly Phase 1
Chemipharm Pharmaceutical Industries, EgyptPhase 1
Genuine Research Center, EgyptPhase 1

See all MODAFINIL clinical trials

Pharmacology for MODAFINIL

US Patents and Regulatory Information for MODAFINIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic MODAFINIL modafinil TABLET;ORAL 202700-001 Oct 18, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Inc MODAFINIL modafinil TABLET;ORAL 076715-002 Nov 1, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd MODAFINIL modafinil TABLET;ORAL 202566-001 Sep 27, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex MODAFINIL modafinil TABLET;ORAL 077667-002 Feb 3, 2014 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma Pharms MODAFINIL modafinil TABLET;ORAL 090543-002 Sep 26, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd MODAFINIL modafinil TABLET;ORAL 202566-002 Sep 27, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.